CS logo
small CS logo
Charité - Universitätsmedizin Berlin Institute of Allergology

Berlin, Germany
Krankenhausabteilung in Berlin

About Charité - Universitätsmedizin Berlin Institute of Allergology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Blueprint Medicines Corporation
1
Third Harmonic Bio, Inc.
1
Total Rows: 2

Clinical Trials at Charité - Universitätsmedizin Berlin Institute of Allergology


During the past decade, Charité - Universitätsmedizin Berlin Institute of Allergology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110000Started TrialsCompleted Trails2021202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
2021-11-30
2028-06-30
Recruiting
443
A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria
2022-09-06
2023-09-01
Suspended
5

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBlueprint MedicinesCorporation: 1Blueprint MedicinesCorporation: 1Third Harmonic Bio, Inc.: 1Third Harmonic Bio, Inc.: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Charité - Universitätsmedizin Berlin Institute of Allergology


According to Clinical.Site data, the most researched conditions in "Charité - Universitätsmedizin Berlin Institute of Allergology" are "Chronic Cold Urticaria" (1 trials), "Indolent Systemic Mastocytosis" (1 trials) and "Monoclonal Mast Cell Activation Syndrome" (1 trials). Many other conditions were trialed in "Charité - Universitätsmedizin Berlin Institute of Allergology" in a lesser frequency.

Clinical Trials Intervention Types at Charité - Universitätsmedizin Berlin Institute of Allergology


Most popular intervention types in "Charité - Universitätsmedizin Berlin Institute of Allergology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "BLU-263" (1 trials), "Placebo" (1 trials) and "THB001" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Charité - Universitätsmedizin Berlin Institute of Allergology


The vast majority of trials in "Charité - Universitätsmedizin Berlin Institute of Allergology" are 2 trials for "All" genders.

Clinical Trials Status at Charité - Universitätsmedizin Berlin Institute of Allergology


Currently, there are NaN active trials in "Charité - Universitätsmedizin Berlin Institute of Allergology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Charité - Universitätsmedizin Berlin Institute of Allergology, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Charité - Universitätsmedizin Berlin Institute of Allergology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 1Recruiting: 1Suspended: 1Suspended: 1